Technical Analysis for TYME - Tyme Technologies, Inc.

Grade Last Price % Change Price Change
grade F 2.2 2.80% 0.06
TYME closed up 2.8 percent on Friday, April 20, 2018, on 53 percent of normal volume.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Up
See historical TYME trend table...

Date Alert Name Type % Chg
Apr 20 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Apr 20 Bollinger Band Squeeze Range Contraction 0.00%
Apr 20 Narrow Range Bar Range Contraction 0.00%
Apr 19 180 Bearish Setup Bearish Swing Setup 2.80%
Apr 19 Bollinger Band Squeeze Range Contraction 2.80%
Apr 19 Narrow Range Bar Range Contraction 2.80%
Apr 19 NR7 Range Contraction 2.80%
Apr 19 Inside Day Range Contraction 2.80%
Apr 18 Bollinger Band Squeeze Range Contraction 0.46%
Apr 17 Bollinger Band Squeeze Range Contraction 3.77%

Older signals for TYME ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Tyme Technologies, Inc., formerly Global Group Enterprises Corp., conducts majority of its research and development activities and other business operations, through its subsidiary, Tyme Inc. (Tyme). Tyme is a clinical-stage biopharmaceutical company. Tyme is focused on the development and commercialization of highly targeted cancer therapeutics with a range of oncology indications. The Company's another subsidiary, Luminant Biosciences, LLC, conducts the initial research and development of the Company's therapeutic platform. The Company is formulating its regulatory and drug development program for its lead drug candidate, SM-88, and working towards the initiation of its Phase II clinical trial. The Company is also evaluating the expansion of its Phase II program to other types of cancer. The Company has not generated any revenue.
Is TYME a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.5
52 Week Low 2.01
Average Volume 352,246
200-Day Moving Average 0.0
50-Day Moving Average 2.656
20-Day Moving Average 2.177
10-Day Moving Average 2.15
Average True Range 0.1601
ADX 19.02
+DI 14.29
-DI 18.3
Chandelier Exit (Long, 3 ATRs ) 1.9597
Chandelier Exit (Short, 3 ATRs ) 2.4903
Upper Bollinger Band 2.3132
Lower Bollinger Band 2.0408
Percent B (%b) 0.58
BandWidth 12.512632
MACD Line -0.1477
MACD Signal Line -0.2039
MACD Histogram 0.0562
Fundamentals Value
Market Cap 196.51 Million
Num Shares 89.3 Million
EPS -0.14
Price-to-Earnings (P/E) Ratio -15.71
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.32
Resistance 3 (R3) 2.31 2.25 2.30
Resistance 2 (R2) 2.25 2.22 2.26 2.29
Resistance 1 (R1) 2.23 2.20 2.24 2.24 2.29
Pivot Point 2.17 2.17 2.18 2.18 2.17
Support 1 (S1) 2.15 2.14 2.16 2.16 2.11
Support 2 (S2) 2.09 2.12 2.10 2.11
Support 3 (S3) 2.07 2.09 2.10
Support 4 (S4) 2.08